Bidirectional Association between Sarcopenia and Depressive Symptoms among Chinese Middle- and Older-Aged Adults: Longitudinal Observational Study

Na Zeng,Chao Li,Huan Mei,Shuilin Wu,Chang Liu,Xiaokun Wang,Jie Shi,Lin Lu,Yanping Bao
DOI: https://doi.org/10.3390/brainsci14060593
IF: 3.333
2024-06-12
Brain Sciences
Abstract:Background: The study aimed to examine the bidirectional relationship between sarcopenia and depressive symptoms in a national, community-based cohort study, despite the unclear temporal sequence demonstrated previously. Methods: Data were derived from four waves (2011 baseline and 2013, 2015, and 2018 follow-ups) of the China Health and Retirement Longitudinal Study (CHARLS). A total of 17,708 participants aged 45 years or older who had baseline data on both sarcopenia status and depressive symptoms in 2011 were included in the study. For the two cohort analyses, a total of 8092 adults without depressive symptoms and 11,292 participants without sarcopenia in 2011 were included. Sarcopenia status was defined according to the Asian Working Group for Sarcopenia 2019 (AWGS 2019) criteria. Depressive symptoms were defined as a score of 20 or higher on the 10-item Center for Epidemiologic Studies Depressive Scale (CES-D-10). Cox proportional hazard regression models were conducted to examine the risk of depressive symptoms and sarcopenia risk, while cross-lagged panel models were used to examine the temporal sequence between depressive symptoms and sarcopenia over time. Results: During a total of 48,305.1 person-years follow-up, 1262 cases of incident depressive symptoms were identified. Sarcopenia exhibited a dose–response relationship with a higher risk of depressive symptoms (HR = 1.7, 95%CI: 1.2–2.3 for sarcopenia, and HR = 1.5, 95%CI: 1.2–1.8 for possible sarcopenia, p trend < 0.001). In the second cohort analysis, 240 incident sarcopenia cases were identified over 39,621.1 person-years. Depressive symptoms (HR = 1.5, 95%CI: 1.2–2.0) are significantly associated with a higher risk of developing sarcopenia after multivariable adjustment (p < 0.001, Cross-lagged panel analyses demonstrated that depressive symptoms were associated with subsequent sarcopenia (β = 0.003, p < 0.001). Simultaneously, baseline sarcopenia was also associated with subsequent depressive symptoms (β = 0.428, p < 0.001). Conclusion: This study identified a bidirectional relationship between depressive symptoms and sarcopenia. It seems more probable that baseline sarcopenia is associated with subsequent depressive symptoms in a stronger pattern than the reverse pathway. The interlinkage indicated that maintaining normal muscle mass and strength may serve as a crucial intervention strategy for alleviating mood disorders.
neurosciences
What problem does this paper attempt to address?
### Problems the Paper Attempts to Solve This paper aims to explore the bidirectional relationship between sarcopenia and depressive symptoms in middle-aged and older adults in China, and to clarify the temporal sequence between the two through a longitudinal observational study. #### Research Background - **Research Objective**: To investigate the bidirectional relationship between sarcopenia and depressive symptoms through a nationwide community-based cohort study. - **Research Methods**: Data were sourced from four waves of the China Health and Retirement Longitudinal Study (CHARLS) (2011 baseline and follow-ups in 2013, 2015, and 2018). A total of 17,708 participants aged 45 and above in 2011 with baseline data on sarcopenia and depressive symptoms were included. Two cohort analyses respectively included 8,092 participants without depressive symptoms and 11,292 participants without sarcopenia. - **Assessment Criteria**: Sarcopenia was defined according to the Asian Working Group for Sarcopenia (AWGS 2019) criteria, and depressive symptoms were assessed using the 10-item Center for Epidemiologic Studies Depression Scale (CES-D-10). - **Statistical Analysis**: Cox proportional hazards regression models were used to analyze the risk of depressive symptoms and sarcopenia, and cross-lagged panel models were used to explore the temporal sequence between depressive symptoms and sarcopenia. #### Main Findings - During a total follow-up of 48,305.1 person-years, 1,262 new cases of depressive symptoms were identified. Sarcopenia was associated with a higher risk of depressive symptoms in a dose-response manner (HR = 1.7, 95%CI: 1.2–2.3). - In the second cohort analysis, during a total follow-up of 39,621.1 person-years, 240 new cases of sarcopenia were identified. Depressive symptoms significantly increased the risk of developing sarcopenia (HR = 1.5, 95%CI: 1.2–2.0). - Cross-lagged panel analysis indicated that depressive symptoms were associated with subsequent sarcopenia (β = 0.003, p < 0.001), and baseline sarcopenia was also associated with subsequent depressive symptoms (β = 0.428, p < 0.001). #### Conclusion - The study reveals a bidirectional relationship between depressive symptoms and sarcopenia. The relationship between baseline sarcopenia and subsequent depressive symptoms is stronger. - Maintaining normal muscle mass and strength may serve as a key intervention strategy to alleviate mood disorders. Through these findings, the authors hope to provide a basis for early detection and intervention, thereby effectively managing diseases and improving overall quality of life.